TrialPanorama/TrialPanorama-database huggingface dataset:
Study 20716591 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 20716591 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 20716591 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 20716591 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 20718769 — Surrogate Endpoint (SUR): Bone mineral density
Study 20719839 — Surrogate Endpoint (SUR): Blood pressure
Study 20720216 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20724537 — Surrogate Endpoint (SUR): Hematologic response
Study 20725912 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 19
Genes: FGF19; UNQ334/PRO533
Study 20731625 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 20732988 — Predictive Biomarker (PRD): FUT1 mRNA
Genes: FUT1; H; HSC
Study 20733093 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 20733093 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 20733093 — Surrogate Endpoint (SUR): Blood pressure
Study 20739388 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 20739388 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 20739421 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 20739682 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 20739682 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20739682 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 20797845 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 20803190 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 20807873 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 20811392 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study 20812791 — Predictive Biomarker (PRD): RRAD mRNA
Genes: RRAD; RAD
Study 20812850 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 20813797 — Surrogate Endpoint (SUR): Blood pressure
Study 20814413 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 20814413 — Surrogate Endpoint (SUR): Serum triglycerides
Study 20816019 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 20816019 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20816019 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 20816019 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 20818854 — Predictive Biomarker (PRD): COL7A1 mRNA
Genes: COL7A1
Study 20818854 — Monitoring Biomarker (MOI): Complement C7
Genes: C7
Study 20819467 — Predictive Biomarker (PRD): SIT1 mRNA
Genes: SIT1; SIT
Study 20822542 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 20822542 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20822542 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 20823423 — Predictive Biomarker (PRD): RAPGEF5 mRNA
Genes: RAPGEF5; GFR; KIAA0277; MRGEF
Study 20823423 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 20826251 — Surrogate Endpoint (SUR): Blood pressure
Study 20827267 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 20827267 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ESR2 mRNA
Genes: ESR2; ESTRB; NR3A2
Study 20827267 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 20827267 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 20832596 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 20837778 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20837778 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 20837881 — Surrogate Endpoint (SUR): Blood pressure
Study 20837883 — Surrogate Endpoint (SUR): Blood pressure
Study 20838998 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 20838998 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study 20838998 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 20840760 — Surrogate Endpoint (SUR): Serum creatinine
Study 20843246 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study 20843246 — Predictive Biomarker (PRD): JAK2
Genes: JTK10
Study 20843246 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 20843592 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20843592 — Surrogate Endpoint (SUR): Blood pressure
Study 20846604 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 20851481 — Surrogate Endpoint (SUR): Blood pressure
Study 20851928 — Safety Biomarker (SAF): Arginase-1
Genes: ARG1
Study 20854821 — Predictive Biomarker (PRD): STAT1 mRNA
Genes: STAT1
Study 20855799 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 20856802 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study 20856802 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 20856802 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 20856802 — Predictive Biomarker (PRD): LAT mRNA
Genes: LAT
Study 20856865 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study 20856865 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study 20858686 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 20861505 — Predictive Biomarker (PRD): AGTR1 mRNA
Genes: AGTR1; AGTR1A; AGTR1B; AT2R1; AT2R1B
Study 20863431 — Surrogate Endpoint (SUR): Platelet count response
Study 20871389 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 20874659 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 20874659 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 20874659 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 20874827 — Predictive Biomarker (PRD): LY6K mRNA
Genes: LY6K; CO16
Study 20874827 — Predictive Biomarker (PRD): TTK mRNA
Genes: TTK; MPS1; MPS1L1
Study 20874827 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 20875102 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 20875102 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study 20875102 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 20876670 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 20876670 — Surrogate Endpoint (SUR): Serum sodium
Study 20877297 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 20879880 — Predictive Biomarker (PRD): MYCN mRNA
Genes: MYCN; BHLHE37; NMYC
Study 20881264 — Predictive Biomarker (PRD): IHH mRNA
Genes: IHH
Study 20881264 — Predictive Biomarker (PRD): SMO mRNA
Genes: SMO; SMOH
Study 20881264 — Predictive Biomarker (PRD): Protein patched homolog 1
Genes: PTCH1; PTCH
Study 20881264 — Predictive Biomarker (PRD): Zinc finger protein GLI1
Genes: GLI1; GLI
Study 20881264 — Predictive Biomarker (PRD): GLI2 mRNA
Genes: GLI2; THP
Study 20881954 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 20881954 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 20881954 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 20881954 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 20881954 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 20881954 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 20883227 — Surrogate Endpoint (SUR): Blood pressure
Study 20883227 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 20883929 — Predictive Biomarker (PRD): CALD1 mRNA
Genes: CALD1; CAD; CDM
Study 20888065 — Predictive Biomarker (PRD): TLR9
Genes: CD289
Study 20888135 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 20888135 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 20888135 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 20888135 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study 20920370 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study 20921541 — Predictive Biomarker (PRD): CALD1 mRNA
Genes: CALD1; CAD; CDM
Study 20922800 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 20922800 — Surrogate Endpoint (SUR): Serum creatinine
Study 20923256 — Surrogate Endpoint (SUR): Bone mineral density
Study 20923544 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 20923561 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 20924570 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 20924570 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 20925950 — Predictive Biomarker (PRD): DCT mRNA
Genes: DCT; TYRP2
Study 20926522 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 20926522 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 20926522 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 20926522 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 20926522 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 20930086 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 20930086 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 20930086 — Surrogate Endpoint (SUR): Serum creatinine
Study 20930628 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study 20932222 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 20932222 — Surrogate Endpoint (SUR): Blood pressure
Study 20934233 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study 20937945 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 20937945 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 20937945 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 20937945 — Predictive Biomarker (PRD): CD83 mRNA
Genes: CD83
Study 20937945 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study 20939732 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 20940416 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 20940416 — Predictive Biomarker (PRD): SYK mRNA
Genes: SYK
Study 20940416 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 20943702 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 20950306 — Surrogate Endpoint (SUR): Bone mineral density
Study 20950306 — Surrogate Endpoint (SUR): Serum testosterone
Study 20952687 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 20952687 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 20952687 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 20955442 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20955704 — Monitoring Biomarker (MOI): HBV DNA
Study 20956472 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 20956472 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 20956472 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study 20956803 — Predictive Biomarker (PRD): IRF4 mRNA
Genes: IRF4; MUM1
Study 20956803 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 20962157 — Predictive Biomarker (PRD): PNPLA3 mRNA
Genes: PNPLA3; ADPN; C22orf20
Study 20965785 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 20965785 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 20966039 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study 20967254 — Surrogate Endpoint (SUR): Blood pressure
Study 20967484 — Predictive Biomarker (PRD): UCN mRNA
Genes: UCN
Study 20976246 — Pharmacodynamic Biomarker (PDY): Fatty acid amide hydrolase 1
Genes: FAAH; FAAH1
Study 20976246 — Predictive Biomarker (PRD): MGLL mRNA
Genes: MGLL
Study 20977712 — Predictive Biomarker (PRD): EBF1 mRNA
Genes: EBF1; COE1; EBF
Study 20977712 — Predictive Biomarker (PRD): ERF mRNA
Genes: ERF
Study 20978227 — Surrogate Endpoint (SUR): Blood pressure
Study 20979469 — Predictive Biomarker (PRD): EML4 mRNA
Genes: EML4; C2orf2; EMAPL4
Study 20979469 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 20979472 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 20981430 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 21030492 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 21030496 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 21030496 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 21030558 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 21030558 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21030558 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 21030579 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 21034418 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study 21034448 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 21034448 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MUC5AC mRNA
Genes: MUC5AC; MUC5
Study 21035624 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study 21041183 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 21041183 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 21047225 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 21047927 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 21051706 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 21055747 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 21055747 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 21055747 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 21055747 — Predictive Biomarker (PRD): RUNX1 mRNA
Genes: RUNX1; AML1; CBFA2
Study 21055747 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 21055747 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 21057003 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 21060028 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 21060028 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 21060320 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 21062137 — Surrogate Endpoint (SUR): Serum potassium
Study 21062463 — Surrogate Endpoint (SUR): Bone mineral density
Study 21071497 — Surrogate Endpoint (SUR): Serum creatinine
Study 21071966 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 21072184 — Predictive Biomarker (PRD): SLCO1B1 mRNA
Genes: SLCO1B1; LST1; OATP1B1; OATP2; OATPC; SLC21A6
Study 21072184 — Safety Biomarker (SAF): SLCO1B1
Genes: OATP-C; LST-1; OATP1B1
Study 21072184 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MRP2
Genes: ABCC2; DJS; cMRP
Study 21072184 — Predictive Biomarker (PRD): ABCG2 mRNA
Genes: ABCG2; ABCP; BCRP; BCRP1; MXR
Study 21072603 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 21072603 — Safety Biomarker (SAF): BDNF
Study 21078419 — Predictive Biomarker (PRD): LORICRIN mRNA
Genes: LORICRIN; LOR; LRN
Study 21083386 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21084397 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study 21084397 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 21086905 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21087953 — Predictive Biomarker (PRD): CNTF mRNA
Genes: CNTF
Study 21087958 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 21088439 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 21088439 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 21091740 — Predictive Biomarker (PRD): IK mRNA
Genes: IK; RED; RER
Study 21093448 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 21093448 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study 21093448 — Predictive Biomarker (PRD): CD83 mRNA
Genes: CD83
Study 21093448 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21093448 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 21095016 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study 21095016 — Predictive Biomarker (PRD): ANKK1 mRNA
Genes: ANKK1; PKK2; SGK288
Study 21098399 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 21098399 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 21098574 — Predictive Biomarker (PRD): CXCL13 mRNA
Genes: CXCL13; BCA1; BLC; SCYB13
Study 21098574 — Monitoring Biomarker (MOI): Matrix metalloproteinase 1
Genes: MMP1; CLG
Study 21098574 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Matrix metalloproteinase 3
Genes: MMP3; STMY1
Study 21106711 — Predictive Biomarker (PRD): CYP19A1 mRNA
Genes: CYP19A1; ARO1; CYAR; CYP19
Study 21106711 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 21106722 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21106722 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 21107682 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 21111983 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 21115606 — Surrogate Endpoint (SUR): Forced vital capacity
Study 21117946 — Surrogate Endpoint (SUR): Blood pressure
Study 21123449 — Surrogate Endpoint (SUR): Blood pressure
Study 21126328 — Predictive Biomarker (PRD): HDGFL2 mRNA
Genes: HDGFL2; HDGF2; HDGFRP2; HRP2; UNQ785/PRO1604
Study 21134574 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21134978 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 21134978 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 21134978 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 21134978 — Predictive Biomarker (PRD): HRAS mRNA
Genes: HRAS; HRAS1
Study 21134978 — Predictive Biomarker (PRD): MRAS mRNA
Genes: MRAS; RRAS3
Study 21134985 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study 21134985 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 21135146 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 21135251 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study 21135251 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 21135251 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 21138939 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 21140148 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 21140148 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study 21145590 — Surrogate Endpoint (SUR): Hematologic response
Study 21148082 — Predictive Biomarker (PRD): CD2 mRNA
Genes: CD2; SRBC
Study 21148082 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 21148082 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study 21148082 — Predictive Biomarker (PRD): KIT
Genes: CD117; SCFR; C-Kit
Study 21148082 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 21148334 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study 21148530 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21148532 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21149673 — Predictive Biomarker (PRD): ALPK1 mRNA
Genes: ALPK1; KIAA1527; LAK
Study 21149673 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21149673 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study 21149673 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 21150563 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21150709 — Predictive Biomarker (PRD): TLR7 mRNA
Genes: TLR7; UNQ248/PRO285
Study 21150709 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21150884 — Predictive Biomarker (PRD): ADIPOQ mRNA
Genes: ADIPOQ; ACDC; ACRP30; APM1; GBP28
Study 21150884 — Surrogate Endpoint (SUR): Blood pressure
Study 21156020 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 21156020 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 21159841 — Surrogate Endpoint (SUR): Bone mineral density
Study 21167034 — Surrogate Endpoint (SUR): Blood pressure
Study 21167034 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21168818 — Predictive Biomarker (PRD): CYP1B1 mRNA
Genes: CYP1B1